Jam

Harbour BioMed has increased its ownership in Spruce Biosciences to approximately 3.8%, marking a deeper strategic alliance beyond a traditional licensing agreement. This move underscores Harbour BioMed’s confidence in Spruce’s SPR202 antibody therapy and their collaborative efforts to accelerate novel antibody treatments for conditions like congenital adrenal hyperplasia. The expanded partnership signifies a shared commitment to bringing innovative therapies to patients.

Assurant has acquired RL Circular Operations, formerly TIC Reverse Logistics, expanding its post-purchase and circular economy capabilities in the APAC region. This move strengthens Assurant’s ability to manage the product lifecycle, reduce waste, and enhance asset value for retailers and manufacturers. The integration aims to leverage AI technologies for sustainable practices, optimize device lifecycle management, and improve consumer experiences across Australia and New Zealand.

Wildsky Resources has granted 2.1 million incentive stock options to its officers, directors, and consultants, with an exercise price of $0.17 per share. These options, expiring in five years, aim to align key personnel with the company’s long-term performance. This strategic compensation move is designed to attract and retain talent within the junior exploration sector. The grant may lead to future dilution depending on option exercise and overall share count.

Canada’s reduction of tariffs on Chinese EVs from 100% to 6.1% significantly benefits Lotus Technology. This policy shift is expected to halve the price of Lotus’s Eletre in Canada, boosting wholesale deliveries. With North American homologation complete and a dealership network in place, Lotus is well-positioned to capitalize on this opportunity, which complements its strategic investments and product expansion plans. The tariff change specifically aids Chinese-manufactured premium EVs, unlike broader market trends.

4D Molecular Therapeutics has granted 23,600 RSUs to four new employees under its 2025 Employment Inducement Award Plan. This move reflects the company’s strategy to attract and retain key talent in the competitive biotech sector. These inducement grants, common in the industry, are intended to incentivize new hires and support the advancement of the company’s gene therapy pipeline, including its lead candidate 4D-150.

Abu Dhabi has launched its first fully driverless commercial robotaxi service, a collaboration between Baidu’s Apollo Go and local firm AutoGo. Initially available on Yas Island via the AutoGo app, this initiative aims to deploy hundreds of autonomous vehicles by 2026, creating Abu Dhabi’s largest driverless fleet. The service, backed by strong regulatory support, is set to expand to other key islands and eventually across the emirate, building on Apollo Go’s extensive global operational experience.

Micron Technology is acquiring Powerchip Semiconductor Manufacturing Corporation’s P5 fabrication facility in Taiwan for $1.8 billion. This strategic move adds 300,000 square feet of cleanroom space and is expected to significantly boost Micron’s DRAM production capacity. The deal also includes a long-term partnership with PSMC for post-wafer assembly. Meaningful wafer output is anticipated to commence in the second half of 2027.

Jayud Global Logistics faces a securities fraud class action lawsuit for alleged “pump-and-dump” activities between April 2023 and April 2025. Investors must act by January 20, 2026, to be considered for lead plaintiff. Despite recent strategic acquisitions and expansion announcements, the company’s stock has underperformed, and market reactions to operational news appear muted amidst ongoing legal challenges.

Renegade Gold granted 3,025,000 stock options to directors, officers, and consultants, exercisable at $0.52 per share for three years. This aims to align executive interests with shareholder value and motivate key personnel as the company advances its exploration projects in the Red Lake Mining District. The immediate vesting encourages engagement, though potential dilution for existing shareholders is a consideration.

GBank Financial Holdings will release its Q4 and full-year 2025 earnings on January 28, 2026, at 1:15 p.m. PST, followed by a virtual earnings call. The company’s Q3 2025 results showed $4.3 million in net income and $20.2 million in net revenue. Investors will focus on loan growth, credit loss provisions, and capital adequacy, especially after issuing $11 million in subordinated notes. The company also recently received approval for a cashless wagering partnership.